PROTEXT MOBILITY INC.. ($TXTM) Master institutional Presentation Deck. 2026

Hinzugefügt: 2026-05-22

[00:00:00]Protext Mobility Incorporated. Master Institutional Presentation Deck. Welcome to Protext Mobility Incorporated, ticker symbol TXTM, a company engineering the infrastructure layer between biology, pharmaceutical science, and digital capital markets. At the convergence of next-generation biotechnology, active pharmaceutical ingredient infrastructure, live plant extraction technology, nanotechnology enhanced bioavailability, real-world asset infrastructure, tokenization, and digital financial systems. TXTM is positioning itself to participate in one of the most significant industrial transformations of the modern era. This is more than a company. This is the emergence of biological to digital infrastructure. TXTM's evolution represents a strategic transition from legacy corporate structure into a vertically integrated biotechnology and infrastructure platform. The company is aligning multiple operational layers across biological science, pharmaceutical engineering, advanced extraction technologies, nanotechnology delivery systems, and tokenized real-world asset infrastructure. Rather than operating within a single industry silo, TXTM is positioning itself at the convergence of biology, pharmaceutical science, and digital finance. The objective is clear: to build scalable infrastructure capable of bridging physical biological systems with next-generation digital capital markets.

[00:01:27]The broader TXTM ecosystem builds upon years of strategic development associated with the RSAMMD framework and South African infrastructure initiatives. This foundation includes early cannabinoid advocacy, pharmaceutical-focused botanical research, cultivation infrastructure development, agricultural network establishment, and long-term regulatory positioning experience. Over time, these foundational layers helped establish access pathways into cultivation systems, permits, clinical and patient-centered wellness models, and international industry relationships. The result is the development of an ecosystem designed to bridge agriculture, science, pharmaceutical development, and digital finance into a unified infrastructure framework. The world is entering a transformational shift. Global demand is accelerating toward plant-based therapeutics, high bioavailability active pharmaceutical ingredients, sustainable health care systems, and tokenized financial infrastructure. At the same time, traditional biotechnology models remain highly capital intensive, slow to scale, and disconnected from emerging digital liquidity systems.

[00:02:37]TXTM's strategy seeks to unify these fragmented industries into a scalable infrastructure model designed for the next generation of global markets.

[00:02:46]Protext Mobility's operational model is structured across six integrated infrastructure layers: biological production, live plant extraction, API engineering, nanotechnology enhanced delivery systems, digital infrastructure, and institutional capital access. Each layer is designed to strengthen the next, creating a vertically integrated architecture capable of supporting scalable pharmaceutical and digital financial ecosystems. This layered structure represents infrastructure, not speculation. TXTM's live plant extraction systems focus on preserving the molecular integrity of botanical compounds prior to degradation. The objective is to retain full-spectrum phytonutrients while supporting enhanced bioavailability, improved molecular stability, and advanced therapeutic efficiency. By reducing degradation during processing, the company seeks to maximize the biological value of the plant at the molecular level. This represents a shift away from traditional commodity extraction toward pharmaceutical grade scientific engineering. Traditional extraction systems often rely on methods that reduce phytochemical integrity and limit bioavailability.

[00:03:57]TXTM's live plant systems are designed to focus on molecular preservation, nano-enhanced absorption potential, and pharmaceutical grade formulation pathways. The distinction is significant. Commodity extraction focuses on volume. Advanced pharmaceutical engineering focuses on precision, stability, efficiency, and therapeutic optimization. This is where infrastructure begins to separate itself from conventional industry models.

[00:04:23]Protext Mobility's platform architecture follows a vertically integrated progression. Beginning with biological cultivation systems, advancing into live plant extraction processing, then nano-enhanced formulations, followed by pharmaceutical grade active pharmaceutical ingredients, and ultimately, future digital real-world asset representation. Each operational stage is intended to increase value creation potential across the ecosystem.

[00:04:49]From raw biomass to high-value pharmaceutical infrastructure.

[00:04:53]Traditional markets frequently value biological inventory as simple agricultural stock. TXTM's framework explores a different perspective.

[00:05:03]Biological inventory as future pharmaceutical inventory, future digital collateral, and potentially future tokenizable real-world assets. If biological systems become integrated into digital financial infrastructure, the implications for valuation, liquidity access, and balance sheet scalability could become transformative.

[00:05:23]This is the evolution of inventory into infrastructure. Protext Mobility's financial positioning reflects a philosophy centered on long-term infrastructure development and capital discipline. According to the company's balance sheet for the first quarter of 2026, TXTM reports 611,305,630 United States dollars in assets as per USGAAP reporting standards, the company also reflects significant biological asset positioning alongside a minimal liability structure. TXTM has emphasized a zero corporate debt philosophy, no reverse stock splits, and continued insider accumulation with 775 million 655,004 common stock shares being purchased to date with zero being sold, stabilizing the public float. The long-term objective is to align biological infrastructure with institutional grade financial reporting systems capable of supporting scalable global participation. As the ecosystem matures, management's focus remains centered on disciplined expansion, infrastructure scalability, and long-term institutional positioning. As Protext Mobility advances toward institutional readiness, the company is progressing toward IFRS compliance, audited financials, and international reporting standards. This transition is strategically significant.

[00:06:46]IFRS frameworks may provide advanced recognition mechanisms for biological assets, agricultural inventory, production systems, and potential asset revaluation structures. The objective is to build a scalable reporting framework aligned with international institutional standards as infrastructure matures. In an environment where many microcap structures become associated with dilution, toxic debt, and reverse split cycles, TXTM has emphasized a different model.

[00:07:15]Zero corporate debt, no executive salaries since inception, no reverse stock splits, minimal overhead structures, and continued shareholder alignment. The philosophy is centered on long-term infrastructure growth while preserving shareholder value through disciplined capital management. The broader Protext Mobility ecosystem includes access to permits, cultivation operations, industrial hemp infrastructure, regenerative farming methods, propagation programs, genetic development initiatives, eco-farming systems, and sustainable agricultural models. The long-term objective is to build scalable pharmaceutical grade biological supply systems capable of supporting future API production. At scale, agriculture becomes more than farming. It becomes infrastructure for future pharmaceutical manufacturing. The strategic integration with Trulieve Health strengthens TXTM's formulation and wellness infrastructure.

[00:08:10]This includes cannabinoid formulation development, nanotechnology delivery systems, advanced bioavailability strategies, and scalable API commercialization pathways. The integration creates synergies between live plant extraction, pharmaceutical engineering, wellness applications, and next-generation therapeutic development.

[00:08:31]The broader Protext mobility ecosystem also includes access to cannabinoid-focused medical expertise, pharmacology experience, chronic pain therapeutic research, and patient-centered wellness science. The objective is to support future pharmaceutical development pathways built upon scientific integrity, ethical frameworks, and long-term clinical scalability. This is infrastructure intended to support the future evolution of non-opioid therapeutic systems.

[00:08:59]Protext mobility is developing frameworks capable of digitally representing real-world biological and pharmaceutical infrastructure. This includes active pharmaceutical ingredients, biological inventory, agricultural outputs, cultivation systems, carbon credits, and pharmaceutical infrastructure. The strategic objective is to enable future liquidity access, digital collateralization, fractional participation, and blockchain-based transparency across global financial ecosystems. This is where physical infrastructure begins integrating with digital markets. The digital transformation layer is simple in concept, yet profound in implication.

[00:09:38]Biological assets become pharmaceutical inventory, which may become digitally represented real-world assets. This framework could enable scalable liquidity pathways, financial interoperability, blockchain-enabled settlement systems, and new forms of digital monetization infrastructure. The physical world is becoming digital.

[00:09:57]Protex Mobility is positioning itself within that transition. The broader infrastructure vision references strategic institutional frameworks associated with banking, custodial systems, and cross-border financial participation. Referenced infrastructure includes institutions such as BNY Mellon, Standard Bank, Absa, and Melville Douglas. The objective is to support future foreign direct trade, custodial architecture, digital settlement systems, and global liquidity participation within emerging digital asset ecosystems. Protex Mobility's broader vision incorporates environmental, social, and governance principles across its infrastructure strategy. Environmentally, the focus includes regenerative agriculture, carbon integration, and zero-waste biological systems. Socially, the model supports agricultural employment, community enablement, and expanded wellness access. From a governance perspective, the emphasis remains on transparency, capital discipline, and shareholder protection. The objective is scalable growth aligned with sustainable infrastructure principles. South Africa presents significant and strategic advantages within the broader Protex Mobility framework. These include favorable cultivation climates, large-scale agricultural capacity, lower production costs, export positioning, and potential participation within BRICS expansion initiatives and African continental trade frameworks. Combined with USD to ZAR operational leverage, these macroeconomic dynamics may create scalable infrastructure opportunities capable of supporting global participation. Protext Mobility's strategic roadmap progresses through five major phases: infrastructure foundation, API engineering and extraction systems, IFRS transition and audited financials, real-world asset tokenization infrastructure, and ultimately global expansion and exchange uplisting initiatives. Each phase is designed to strengthen the operational and institutional maturity of the ecosystem. Protext Mobility is not positioning itself as simply a cultivation company, not simply a biotechnology startup, and not simply a blockchain concept. The company's broader objective is to build the infrastructure layer between biological production, pharmaceutical science, and digital capital markets. That distinction changes the scale of the vision entirely. The long-term vision is ambitious: to help build the future infrastructure for active pharmaceutical ingredients, tokenized biological assets, high bioavailability wellness systems, and global digital liquidity networks. The objective is to create a scalable bridge between biological production systems and next-generation digital financial infrastructure. A future where biology and finance become interoperable at global scale. In conclusion, Protext Mobility's focus remains centered on science, infrastructure, scalability, capital discipline, and long-term global expansion. As industries continue converging, TXTM is positioning itself to participate within the next generation of biological to digital infrastructure. The evolution has already begun. Protext Mobility is engineering the future infrastructure layer between biology, pharmaceutical science, and global digital capital.

[00:13:15]The next era of infrastructure may not be built solely with steel, concrete, and code. It may also be built with biology. Thank you.